Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction

Hideo K. Takahashi, Dong Xue, Hiromi Iwagaki, Ryuji Tamura, Goutarou Katsuno, Takahito Yagi, Tadashi Yoshino, Shuji Mori, Masahiro Nishibori, Noriaki Tanaka

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Prostaglandin E1 (PGE1) has therapeutic value for transplantations due to its microvascular activity. Interleukin (IL)-18, which is elevated in plasma during the acute rejection after organ transplantation, elicits the expression of intercellular adhesion molecule (ICAM)-1, B7.1, B7.2, CD40, and CD40 ligand (CD40L) on monocytes as well as the production of interferon (IFN)-γ and IL-12 and proliferation of T-cells during the human mixed lymphocyte reaction (MLR) in an in vitro model of acute rejection. In contrast, PGE1 inhibits all the adhesion molecule expression, cytokine production and T-cell proliferation in the presence of IL-18. The effects of PGE1 depend on stimulation of the IP/EP2/EP4-receptor, and thus, PGE1 might have therapeutic potential for treating acute rejection due to its immune regulatory effect.

Original languageEnglish
Pages (from-to)85-92
Number of pages8
JournalClinical Immunology
Volume115
Issue number1 SPEC. ISS.
DOIs
Publication statusPublished - Apr 2005

Fingerprint

Mixed Lymphocyte Culture Test
Alprostadil
Interleukin-18
T-Lymphocytes
CD40 Ligand
Organ Transplantation
Intercellular Adhesion Molecule-1
Interleukin-12
Interferons
Monocytes
Transplantation
Cell Proliferation
Cytokines
Therapeutics

Keywords

  • Adhesion molecule
  • Human
  • IL-18
  • MLR
  • Prostaglandin

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Takahashi, H. K., Xue, D., Iwagaki, H., Tamura, R., Katsuno, G., Yagi, T., ... Tanaka, N. (2005). Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction. Clinical Immunology, 115(1 SPEC. ISS.), 85-92. https://doi.org/10.1016/j.clim.2004.12.001

Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction. / Takahashi, Hideo K.; Xue, Dong; Iwagaki, Hiromi; Tamura, Ryuji; Katsuno, Goutarou; Yagi, Takahito; Yoshino, Tadashi; Mori, Shuji; Nishibori, Masahiro; Tanaka, Noriaki.

In: Clinical Immunology, Vol. 115, No. 1 SPEC. ISS., 04.2005, p. 85-92.

Research output: Contribution to journalArticle

Takahashi, HK, Xue, D, Iwagaki, H, Tamura, R, Katsuno, G, Yagi, T, Yoshino, T, Mori, S, Nishibori, M & Tanaka, N 2005, 'Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction', Clinical Immunology, vol. 115, no. 1 SPEC. ISS., pp. 85-92. https://doi.org/10.1016/j.clim.2004.12.001
Takahashi, Hideo K. ; Xue, Dong ; Iwagaki, Hiromi ; Tamura, Ryuji ; Katsuno, Goutarou ; Yagi, Takahito ; Yoshino, Tadashi ; Mori, Shuji ; Nishibori, Masahiro ; Tanaka, Noriaki. / Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction. In: Clinical Immunology. 2005 ; Vol. 115, No. 1 SPEC. ISS. pp. 85-92.
@article{441acb1373a9474fbc2a18e7496b9f6c,
title = "Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction",
abstract = "Prostaglandin E1 (PGE1) has therapeutic value for transplantations due to its microvascular activity. Interleukin (IL)-18, which is elevated in plasma during the acute rejection after organ transplantation, elicits the expression of intercellular adhesion molecule (ICAM)-1, B7.1, B7.2, CD40, and CD40 ligand (CD40L) on monocytes as well as the production of interferon (IFN)-γ and IL-12 and proliferation of T-cells during the human mixed lymphocyte reaction (MLR) in an in vitro model of acute rejection. In contrast, PGE1 inhibits all the adhesion molecule expression, cytokine production and T-cell proliferation in the presence of IL-18. The effects of PGE1 depend on stimulation of the IP/EP2/EP4-receptor, and thus, PGE1 might have therapeutic potential for treating acute rejection due to its immune regulatory effect.",
keywords = "Adhesion molecule, Human, IL-18, MLR, Prostaglandin",
author = "Takahashi, {Hideo K.} and Dong Xue and Hiromi Iwagaki and Ryuji Tamura and Goutarou Katsuno and Takahito Yagi and Tadashi Yoshino and Shuji Mori and Masahiro Nishibori and Noriaki Tanaka",
year = "2005",
month = "4",
doi = "10.1016/j.clim.2004.12.001",
language = "English",
volume = "115",
pages = "85--92",
journal = "Clinical Immunology",
issn = "1521-6616",
publisher = "Academic Press Inc.",
number = "1 SPEC. ISS.",

}

TY - JOUR

T1 - Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction

AU - Takahashi, Hideo K.

AU - Xue, Dong

AU - Iwagaki, Hiromi

AU - Tamura, Ryuji

AU - Katsuno, Goutarou

AU - Yagi, Takahito

AU - Yoshino, Tadashi

AU - Mori, Shuji

AU - Nishibori, Masahiro

AU - Tanaka, Noriaki

PY - 2005/4

Y1 - 2005/4

N2 - Prostaglandin E1 (PGE1) has therapeutic value for transplantations due to its microvascular activity. Interleukin (IL)-18, which is elevated in plasma during the acute rejection after organ transplantation, elicits the expression of intercellular adhesion molecule (ICAM)-1, B7.1, B7.2, CD40, and CD40 ligand (CD40L) on monocytes as well as the production of interferon (IFN)-γ and IL-12 and proliferation of T-cells during the human mixed lymphocyte reaction (MLR) in an in vitro model of acute rejection. In contrast, PGE1 inhibits all the adhesion molecule expression, cytokine production and T-cell proliferation in the presence of IL-18. The effects of PGE1 depend on stimulation of the IP/EP2/EP4-receptor, and thus, PGE1 might have therapeutic potential for treating acute rejection due to its immune regulatory effect.

AB - Prostaglandin E1 (PGE1) has therapeutic value for transplantations due to its microvascular activity. Interleukin (IL)-18, which is elevated in plasma during the acute rejection after organ transplantation, elicits the expression of intercellular adhesion molecule (ICAM)-1, B7.1, B7.2, CD40, and CD40 ligand (CD40L) on monocytes as well as the production of interferon (IFN)-γ and IL-12 and proliferation of T-cells during the human mixed lymphocyte reaction (MLR) in an in vitro model of acute rejection. In contrast, PGE1 inhibits all the adhesion molecule expression, cytokine production and T-cell proliferation in the presence of IL-18. The effects of PGE1 depend on stimulation of the IP/EP2/EP4-receptor, and thus, PGE1 might have therapeutic potential for treating acute rejection due to its immune regulatory effect.

KW - Adhesion molecule

KW - Human

KW - IL-18

KW - MLR

KW - Prostaglandin

UR - http://www.scopus.com/inward/record.url?scp=20944447139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20944447139&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2004.12.001

DO - 10.1016/j.clim.2004.12.001

M3 - Article

VL - 115

SP - 85

EP - 92

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 1 SPEC. ISS.

ER -